Age and cystatin C in healthy adults: A collaborative study

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 463-469

  Odden, Michelle C ^a,b   Tager, Ira B ^a   Gansevoort, Ron T ^c   Bakker, Stephan J L ^c   Katz, Ronit ^d   Fried, Linda F ^e   Newman, Anne B ^f   Canada, Robert B ^g   Harris, Tamara ^h   Sarnak, Mark J ⁱ   Siscovick, David ^d   Shlipak, Michael G ^e,j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF WASHINGTON   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^h NATIONAL INSTITUTE ON AGING   (United States)

ⁱ TUFTS MEDICAL CENTER   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Ageing; Chronic kidney disease; Cystatin C; Epidemiology

Indexed keywords

CYSTATIN C;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; NORMAL HUMAN; NORMAL VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; CYSTATIN C; HUMANS; KIDNEY; MIDDLE AGED; REFERENCE VALUES;

EID: 75649105740     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp474     Document Type: Article

References (35)

1. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. USRDS 2007 Annual Data Report. Atlas of End-Stage Renal Disease in the United States, 2008
2. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047 (Pubitemid 350074801)
3. Wesson LG. Renal hemodynamics in physiological states. In: Wesson LG (ed). Physiology of the Human Kidney. New York: Grune and Stratton, 1969, 96-108
4. Zhou XJ, Rakheja D, Yu X et al. The aging kidney. Kidney Int 2008; 74: 710-720
5. Fliser D. Ren sanus in corpore sano: the myth of the inexorable decline of renal function with senescence. Nephrol Dial Transplant 2005; 20: 482-485
6. Levey AS. Measurement of renal function in chronic renal disease. Kidney Int 1990; 38: 167-184
7. Lamb EJ, O'Riordan SE, Delaney MP. Kidney function in older people: pathology, assessment and management. Clin Chim Acta 2003; 334: 25-40
8. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-226
9. Shlipak MG, Praught ML, Sarnak MJ. Update on cystatin C: new insights into the importance of mild kidney dysfunction. Curr Opin Nephrol Hypertens 2006; 15: 270-275
10. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37: 79-83
11. Fried LP, Borhani NO, Enright P et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991; 1: 263-276
12. Bild DE, Bluemke DA, Burke GL et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871-881
13. Gansevoort RT, Verhave JC, Hillege HL et al. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int Suppl 2005; 94: S28-S35
14. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002; 106: 1777-1782
15. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 1999; 59: 1-8
16. Finney H, Newman DJ, Gruber W et al. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43(6 Pt 1): 1016-1022
17. Stevens LA, Coresh J, Schmid CH et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406
18. Brantsma AH, Bakker SJ, Hillege HL et al. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 2005; 28: 2525-2530
19. Burnett RW, D'Orazio P, Fogh-Andersen N et al. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta 2001; 307: 205-209
20. Sinisi SE, Van Der Laan MJ. Deletion/substitution/addition algorithm in learning with applications in genomics. Stat Appl Genet Mol Biol 2004; 3: Article18
21. Edwards MS, Wilson DB, Craven TE et al. Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis 2005; 46: 214-224
22. Lewis J, Greene T, Appel L et al. A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol 2004; 15: 3175-3183
23. Daugirdas JT, Levin NW, Kotanko P et al. Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area. Semin Dial 2008; 21: 377-384
24. Kachadorian WA, Johnson RE. Renal responses to various rates of exercise. J Appl Physiol 1970; 28: 748-752
25. Singer MA. Of mice and men and elephants: metabolic rate sets glomerular filtration rate. Am J Kidney Dis 2001; 37: 164-178
26. Lindeman RD. Overview: renal physiology and pathophysiology of aging. Am J Kidney Dis 1990; 16: 275-282
27. Timiras PS. Physiological Basis of Aging and Geriatrics. 4th ed New York: Informa Healthcare, 2007
28. Wesson L. Renal hemodynamics in physiolgical states. Physiology of the Human Kidney. New York, NY: Grune and Stratton, 1969, 96-108
29. Rowe JW, Andres R, Tobin JD et al. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976; 31: 155-163
30. Kottgen A, Selvin E, Stevens LA et al. Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2008; 51: 385-394
31. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 1950; 29: 496-507
32. Tager IB, Segal MR, Speizer FE et al. The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. Am Rev Respir Dis 1988; 138: 837-849
33. Tanner JM. Fetus into Man. Boston, MA: Harvard University Press, 1978
34. Wang X, Dockery DW, Wypij D et al. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993; 15: 75-88
35. Xu X, Laird N, Dockery DW et al. Age, period, and cohort effects on pulmonary function in a 24-year longitudinal study. Am J Epidemiol 1995; 141: 554-566